Liver function tests and metabolic-associated fatty liver disease: Changes in upper normal limits, does it really matter?

doi:10.4254/wjh.v13.i12.2104

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 12

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4219)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-1) series.

Item

Count

PDF

220

WORD

HTML

1777

Figures (1-3)

200

Tables (1-1)

152

Sum=2437

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

324

Download

773

Sum=1097

Publishing Process of This Article

Item

Count

Browse

269

Download

416

Sum=685

Dec 27, 2021 (publication date) through Apr 26, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Hepatol. Dec 27, 2021; 13(12): 2104-2112
Published online Dec 27, 2021. doi: 10.4254/wjh.v13.i12.2104

Full Size Figure Download Figure

Figure 2 Diagnosis of metabolic-associated steato-hepatitis in three subgroups of patients stratified for alanine aminotransferase levels. ALT: Alanine aminotransferase; pts: Patients; MASH: Metabolic-associated steato-hepatitis.

Citation: Forlano R, Mullish BH, Dhar A, Goldin RD, Thursz M, Manousou P. Liver function tests and metabolic-associated fatty liver disease: Changes in upper normal limits, does it really matter? World J Hepatol 2021; 13(12): 2104-2112
URL: https://www.wjgnet.com/1948-5182/full/v13/i12/2104.htm
DOI: https://dx.doi.org/10.4254/wjh.v13.i12.2104